Budget impact analysis of sFlt-1/PlGF ratio as prediction test in Italian women with suspected preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 30, Issue 18, 2017, Pages 2166-2173

  Frusca, Tiziana ^a   Gervasi, Maria Teresa ^b   Paolini, Davide ^c   Dionisi, Matteo ^c   Ferre, Francesca ^d,e   Cetin, Irene ^f  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Roche Diagnostics   (Italy)

^d SCUOLA SUPERIORE SANT ANNA   (Italy)

^e Temas srl   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

budget impact; PlGF; Preeclampsia; sFlt; sFlt 1

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER;

ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; ECONOMIC ASPECT; GESTATION PERIOD; HEALTH CARE COST; HEALTH SERVICE; HUMAN; IMMUNOASSAY ANALYZER; INTERMETHOD COMPARISON; ITALIAN (CITIZEN); PRACTICE GUIDELINE; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; VALIDATION STUDY; BLOOD; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; IMMUNOASSAY; ITALY; METABOLISM; PREDICTIVE VALUE; PREGNANCY; PROCEDURES; RISK FACTOR; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

BIOMARKERS; COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; HUMANS; IMMUNOASSAY; ITALY; PLACENTA GROWTH FACTOR; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 85011663142     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767058.2016.1242122     Document Type: Article

References (27)

1. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death:a systematic review. Lancet 2006;367:1066–74
2. Duley L., The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7
3. Society of Obstetricians and Gynecologist of Canada (SOGC) Guideline. J Obstet Gynaecol Can 2014;36:416–38
4. Royal College of Obstetricians and Gynecologists (RCOG) Guideline. The management of severe pre-eclampsia/eclampsia. Guideline No. 10(A). 2010. [Internet]. Available from:http://ncagip.ru/for-experts/snk/RCOG.pdf
5. Italian Association of Preeclampsia (AIPE) Guideline 2013. [Internet]. Available from:http://www.preeclampsia.it/images/linee_guida/Linee_Guida_AIPE_2013.pdf
6. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
7. Sibiude J, Guibourdenche J, Dionne M-D, et al. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One 2012;7:e50208
8. Larroca SG-T, Tayyar A, Poon LC, et al. Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30–33 weeks’ gestation. Fetal Diagn Ther 2014;36:9–17
9. Cetin I, Mazzocco MI, Giardini V, et al. PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction. J Matern Fetal Neonatal Med 2017;30:144–9
10. Lapaire O, Shennan A, Stepan H., The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor:current knowledge, clinical implications and future application. Eur J Obstet Gynecol 2010;151:122–9
11. Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 2016;374:13–22
12. Hund M, Allegranza D, Schoedl M, et al. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS):study protocol. BMC Pregn Childbirth 2014;14:324
13. Fattore G. Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia. Pharmacoeconomics-Ital-Res-Articles 2009;11:83
14. National Institute of Statistics (ISTAT) [Internet]. Available from:http://dati.istat.it/
15. National Institute for Health Care Excellence (NICE). Hypertension in pregnancy:the management of hypertensive disorders during pregnancy. Royal College of Obstetricians and Gynecologists. First published August 2010; revised reprint January 2011. [Internet]. Available from:https://www.nice.org.uk/guidance/cg107/evidence/full-guideline-134794333
16. Borghi C, Ferri C, Sechi L., Italian Society of Hypertension. Clinical management of hypertension in pregnancy. Practical recommendations from the Italian Society of Hypertension (SIIA). High Blood Press Cardiovasc Prev 2013;20:123–7
17. Mammaro A, Carrara S, Cavaliere A, et al. Hypertensive disorders in pregnancy. J Prenat Med 2009;3:1–5
18. Vatish M, Strunz-McKendry T, Hund M, et al. The sFlt-1/PlGF ratio test in pre-eclampsia:an economic assessment for the UK. Ultrasound Obstet Gynecol 2016;48:765–71
19. Regione Liguria DGR n°1308 del 24/10/2013, Approvazione del catalogo unico regionale delle prestazioni sanitarie ambulatoriali erogabili sul territorio ligure, National code number 90.53.5:sFlt-1 (Regional code number:C01831800) PlGF (Regional code number:C01850700)
20. Remunerazione delle prestazioni di assistenza ospedaliera per acuti, assistenza ospedaliera di riabilitazione e di lungodegenza post acuzie e di assistenza specialistica ambulatoriale. Decreto Ministeriale del 18 ottobre 2012. Supplemento ordinario alla “Gazzetta Ufficiale” n. 23 del 28 gennaio 2013
21. Xiao R, Sorensen TK, Williams WA, Luthy DA., Influence of pre-eclampsia on fetal growth. J Matern-Fetal Neonat Med 2003;13:157–62
22. Payment by results in the NHS:Tariff Information Spreadsheet [Internet]. Available from:https://www.gov.uk/government/publications/payment-by-results-pbr-operational-guidance-and-tariffs [last accessed Feb 2014]. Exchange rate Pound to Euro, Bank of Italy, 26-08-2015
23. Tan SS, Bakker J, Hoogendoorn ME, et al. Direct cost analysis of intensive care unit stay in four European countries:applying a standardized costing methodology. Value Health 2012;15:81–6
24. Mauskopf JA, Sullivan SD, Annemans L, et al. Principles of good practice for budget impact analysis:report of the ISPOR Task Force on good research practices—budget impact analysis. Value Health 2007;10:336–47
25. Ferré F, de Belvis AG, Valerio L, et al. Italy:Health system review. Health Syst Transit 2014;16:1–168
26. National Institute for Health and Care Excellence. PlGF based testing to help diagnose suspected pre-eclampsia. NICE Guideline [Internet]; 2016. Available from:https://www.nice.org.uk/guidance/dg23/resources
27. Data on File:DOF_sFlt/PIFG_05_16 (Adapted from National Institute for Health and Care Excellence) PlGF based testing to help diagnose suspected pre-eclampsia. NICE resource impact template [Internet]; 2016. Available from:https://www.nice.org.uk/guidance/dg23/resources